2.69
price up icon3.07%   0.08
after-market 시간 외 거래: 2.67 -0.02 -0.74%
loading

Anixa Biosciences Inc 주식(ANIX)의 최신 뉴스

pulisher
Jun 15, 2026

12 Health Care Stocks Moving In Monday's After-Market SessionAlvotech (NASDAQ:ALVO), Anixa Biosciences - Benzinga

Jun 15, 2026
pulisher
Jun 14, 2026

ANIX Q1 2026 Earnings: Narrower-than-expected loss highlights disciplined spending amid clinical developmentGuidance Update - newsline.com

Jun 14, 2026
pulisher
Jun 13, 2026

Anixa Biosciences (ANIX) Holds Near Key Support After Marginal DeclineRisk Reversal - newsline.com

Jun 13, 2026
pulisher
Jun 12, 2026

H.C. Wainwright reiterates Buy on Anixa stock, $7 target By Investing.com - Investing.com Nigeria

Jun 12, 2026
pulisher
Jun 12, 2026

H.C. Wainwright reiterates Buy on Anixa stock, $7 target - Investing.com

Jun 12, 2026
pulisher
Jun 11, 2026

Anixa Biosciences, Inc. (ANIX) Stock Price, News, Quote & History - Yahoo Finance

Jun 11, 2026
pulisher
Jun 11, 2026

Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium - PR Newswire

Jun 11, 2026
pulisher
Jun 10, 2026

Anixa Biosciences Inc 3Q 2026: Net loss $(2.52M), EPS $(0.07) — 10-Q Summary - TradingView

Jun 10, 2026
pulisher
Jun 10, 2026

Anixa Biosciences (NASDAQ: ANIX) trims losses and details cancer pipeline - Stock Titan

Jun 10, 2026
pulisher
Jun 02, 2026

Number of shareholders of Anixa Biosciences, Inc. – GETTEX:CY71 - TradingView

Jun 02, 2026
pulisher
Jun 01, 2026

Anixa Biosciences Holds Steady Near Support as Trading Volume Remains SubduedSuperTrend - The Legal Advocate

Jun 01, 2026
pulisher
Jun 01, 2026

Anixa Biosciences (ANIX) Secures Patent for Ovarian Cancer Vacci - GuruFocus

Jun 01, 2026
pulisher
Jun 01, 2026

Anixa Biosciences (ANIX) Secures Patent for Ovarian Cancer Vaccine Technology - GuruFocus

Jun 01, 2026
pulisher
Jun 01, 2026

Anixa receives Canadian patent allowance for ovarian cancer vaccine By Investing.com - Investing.com Nigeria

Jun 01, 2026
pulisher
Jun 01, 2026

Anixa receives Canadian patent allowance for ovarian cancer vaccine - Investing.com

Jun 01, 2026
pulisher
Jun 01, 2026

Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance - PR Newswire

Jun 01, 2026
pulisher
May 28, 2026

Anixa Biosciences (ANIX) Edges Higher, Tests Key Support ZoneQuality Factor - The Legal Advocate

May 28, 2026
pulisher
May 27, 2026

Anixa Biosciences (ANIX) Holds Steady at $2.73 as Consolidation ContinuesMomentum ETF - The Legal Advocate

May 27, 2026
pulisher
May 26, 2026

Anixa Biosciences (ANIX) Slides 2.15% as Biotech Sector Headwinds ReturnPrice Action Signals - The Legal Advocate

May 26, 2026
pulisher
May 25, 2026

Anixa Biosciences (ANIX) Edges Higher on Above-Average Volume, Testing Key ResistanceGap and Go - newsline.com

May 25, 2026
pulisher
May 22, 2026

Anixa Biosciences Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView

May 22, 2026
pulisher
May 22, 2026

ANIX Stock Price, Quote & Chart | ANIXA BIOSCIENCES INC (NASDAQ:ANIX) - ChartMill

May 22, 2026
pulisher
May 11, 2026

Anixa Biosciences Issues Correction to May 11, 2026 Announcement, Details Available on StockTitan.net - geneonline.com

May 11, 2026
pulisher
May 11, 2026

Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-Cel Ovarian Cancer Car-T Therapy - marketscreener.com

May 11, 2026
pulisher
May 11, 2026

Anixa Biosciences (ANIX) Reports Promising Survival Data from Cl - GuruFocus

May 11, 2026
pulisher
May 11, 2026

Anixa reports survival data from ovarian cancer therapy trial - Investing.com UK

May 11, 2026
pulisher
May 11, 2026

/C O R R E C T I O N -- Anixa Biosciences, Inc./ - PR Newswire

May 11, 2026
pulisher
May 11, 2026

Anixa reports survival data from ovarian cancer therapy trial By Investing.com - Investing.com Australia

May 11, 2026
pulisher
May 11, 2026

Anixa Biosciences Reports Updated Positive Survival Observations From Ongoing Phase 1 Trial Of Lira-Cel Ovarian Cancer CAR-T Therapy - TradingView

May 11, 2026
pulisher
May 11, 2026

Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy - StreetInsider

May 11, 2026
pulisher
May 05, 2026

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer - Quantisnow

May 05, 2026
pulisher
May 04, 2026

Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat - Quantisnow

May 04, 2026
pulisher
May 02, 2026

Anixa Biosciences (NASDAQ:ANIX) Rating Increased to Hold at Wall Street Zen - MarketBeat

May 02, 2026
pulisher
May 01, 2026

Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV - The Malaysian Reserve

May 01, 2026
pulisher
May 01, 2026

Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV - Investing News Network

May 01, 2026
pulisher
May 01, 2026

Bloomberg TV to air Anixa CEO on cancer vaccine and CAR-T data - Stock Titan

May 01, 2026
pulisher
May 01, 2026

Anixia Biosciences and OwlTing Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ChartMill

May 01, 2026
pulisher
Apr 29, 2026

Anixa Biosciences announces issuance of Mexican patent covering breast cancer vaccine technology - marketscreener.com

Apr 29, 2026
pulisher
Apr 29, 2026

Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology - The AI Journal

Apr 29, 2026
pulisher
Apr 29, 2026

Anixa Biosciences (ANIX) Secures Patent for Breast Cancer Vaccine Technology - GuruFocus

Apr 29, 2026
pulisher
Apr 29, 2026

Anixa Biosciences receives Mexican patent for breast cancer vaccine By Investing.com - Investing.com Australia

Apr 29, 2026
pulisher
Apr 29, 2026

Anixa Biosciences receives Mexican patent for breast cancer vaccine - Investing.com

Apr 29, 2026
pulisher
Apr 29, 2026

A breast cancer vaccine gained patent protection in Mexico until 2040 - Stock Titan

Apr 29, 2026
pulisher
Apr 22, 2026

Anixa’s ovarian cancer therapy to be presented at ISCT meeting By Investing.com - Investing.com India

Apr 22, 2026
pulisher
Apr 22, 2026

Anixa’s ovarian cancer therapy to be presented at ISCT meeting - Investing.com

Apr 22, 2026
pulisher
Apr 22, 2026

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting - Nasdaq

Apr 22, 2026
$31.20
price up icon 2.60%
$92.22
price up icon 3.04%
$53.70
price down icon 0.94%
$61.80
price up icon 11.55%
ONC ONC
$262.68
price down icon 0.47%
$157.77
price up icon 0.76%
자본화:     |  볼륨(24시간):